Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gretchen A. Repasky"'
Autor:
John P. Overington, Prson Gautam, Balaguru Ravikumar, Markus Vähä-Koskela, Abhishekh Gupta, Alok Jaiswal, Liye He, Suleiman A. Khan, Gopal Peddinti, Brinton Seashore-Ludlow, Andrew R. Leach, Laxman Yetukuri, Zaid Alam, Mehreen Ali, Arjan J. van Adrichem, Gretchen A. Repasky, Elina Parri, Krister Wennerberg, Anne Hersey, Anna-Lena Gustavsson, Ella Karjalainen, Tero Aittokallio, Anni Rebane, Ziaurrehman Tanoli, Janica Wakkinen, Jing Tang
Publikováno v:
Cell Chemical Biology
Tang, J, Tanoli, Z-R, Ravikumar, B, Alam, Z, Vähä-Koskela, M, Peddinti, G, van Adrichem, A J, Wakkinen, J, Jaiswal, A, Karjalainen, E, Gautam, P, He, L, Parri, E, Khan, S, Gupta, A, Ali, M, Yetukuri, L, Gustavsson, A-L, Seashore-Ludlow, B, Hersey, A, Leach, A R, Overington, J P, Repasky, G, Wennerberg, K & Aittokallio, T 2018, ' Drug Target Commons : A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions ', Cell Chemical Biology, vol. 25, no. 2, pp. 224-229.e2 . https://doi.org/10.1016/j.chembiol.2017.11.009
Tang, J, Tanoli, Z-R, Ravikumar, B, Alam, Z, Vähä-Koskela, M, Peddinti, G, van Adrichem, A J, Wakkinen, J, Jaiswal, A, Karjalainen, E, Gautam, P, He, L, Parri, E, Khan, S, Gupta, A, Ali, M, Yetukuri, L, Gustavsson, A-L, Seashore-Ludlow, B, Hersey, A, Leach, A R, Overington, J P, Repasky, G, Wennerberg, K & Aittokallio, T 2018, ' Drug Target Commons : A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions ', Cell Chemical Biology, vol. 25, no. 2, pp. 224-229.e2 . https://doi.org/10.1016/j.chembiol.2017.11.009
Summary Knowledge of the full target space of bioactive substances, approved and investigational drugs as well as chemical probes, provides important insights into therapeutic potential and possible adverse effects. The existing compound-target bioac
Autor:
Ciarán N. Cronin, Jeffrey H. Chen, Eric Johnson, Gretchen A. Repasky, Michele McTigue, Peter A. Wells, Mika Kontro, Tea Pemovska, Kimmo Porkka, Olli Kallioniemi, Brion W. Murray, Krister Wennerberg
Publikováno v:
Nature. 519:102-105
The BCR-ABL1 fusion gene is a driver oncogene in chronic myeloid leukaemia and 30-50% of cases of adult acute lymphoblastic leukaemia. Introduction of ABL1 kinase inhibitors (for example, imatinib) has markedly improved patient survival, but acquired
Autor:
Ari M. P. Koskinen, Gretchen A. Repasky, Laura Turunen, Arjan J. van Adrichem, Anna Lehto, Krister Wennerberg, Annika E Fagerholm, Jani Saarela
Publikováno v:
Combinatorial Chemistry & High Throughput Screening
University of Helsinki
University of Copenhagen
ResearcherID
University of Helsinki
University of Copenhagen
ResearcherID
The Rho family of Ras superfamily small GTPases regulates a broad range of biological processes such as migration, differentiation, cell growth and cell survival. Therefore, the availability of small molecule modulators as tool compounds could greatl
Publikováno v:
ESMO Open. 3:A431-A432
Introduction Acute myeloid leukaemia (AML) is a malignancy characterised by impaired cell differentiation and uncontrollable accumulation of immature myeloid progenitor cells in the bone marrow. Although most patients respond to the first line chemot
Autor:
Gretchen A. Repasky, Ella Karjalainen
Acute myeloid leukemia (AML) is a hematopoietic malignancy characterized by impaired differentiation and uncontrollable proliferation of myeloid progenitor cells. Due to high relapse rates, overall survival for this rapidly progressing disease is poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72d7ecff7d2ee47673e0225eb2f11cee
https://doi.org/10.1016/bs.pmbts.2016.09.005
https://doi.org/10.1016/bs.pmbts.2016.09.005
Publikováno v:
Molecular Carcinogenesis. 46:958-970
Ras-mediated transformation is associated with upregulation of cyclooxygenase-2 (COX-2), which in turn promotes prostaglandin E2 (PGE2) synthesis and secretion. Although recent studies have identified molecular mechanisms by which Ras mediates upregu
Autor:
Lynn B. Eckert, Channing J. Der, Gretchen A. Repasky, Hong Zhou, Carolyn I. Sartor, Aylin S. Ülkü, Aidan McFall
Publikováno v:
Cancer Research. 64:4585-4592
Although mutated forms of ras are not associated with the majority of breast cancers (
Autor:
Kovanen Rm, Nancy L. Pedersen, Ci Song, Gretchen A. Repasky, Frankowiack M, Lennart Hammarström, Lim Ck
Publikováno v:
Genes and immunity. 16(3)
Serum immunoglobulin A (IgA) concentrations were determined in 12 600 adult Swedish twins, applying a high-throughput reverse-phase protein microarray technique. The prevalence of IgA deficiency (IgAD) was found to be 1:241 in monozygotic (MZ) twins
Publisher Summary This chapter summarizes the general features of R-Ras proteins that are shared with Ras proteins, and then highlights unique features of each R-Ras protein. Ras proteins (H-Ras, K-Ras4A and 4B, and N-Ras) are regulators of signal tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c080bb81bd72995a4f9c96d814cae217
https://doi.org/10.1016/b978-0-12-374145-5.00214-x
https://doi.org/10.1016/b978-0-12-374145-5.00214-x
Tools to study the function of the Ras-related, estrogen-regulated growth inhibitor in breast cancer
Autor:
Ariella B, Hanker, Staeci, Morita, Gretchen A, Repasky, Douglas T, Ross, Robert S, Seitz, Channing J, Der
Publikováno v:
Methods in enzymology. 439
The Ras-related, estrogen-regulated growth inhibitor (Rerg) is a Ras-related small GTPase and candidate tumor suppressor. Rerg gene expression is stimulated by the estrogen receptor alpha (ERalpha), and Rerg gene expression is absent in ER-negative b